A STING-Activating Nanovaccine for Cancer Immunotherapy

Generation of tumor-specific T cells is critically important for cancer immunotherapy(1,2). A major challenge in achieving a robust T cell response is the spatio-temporal orchestration of antigen cross-presentation in antigen presenting cells (APCs) with innate stimulation. Here we report a minimali...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Min, Wang, Hua, Wang, Zhaohui, Cai, Haocheng, Lu, Zhigang, Li, Yang, Du, Mingjian, Huang, Gang, Wang, Chensu, Chen, Xiang, Porembka, Matthew R., Lea, Jayanthi, Frankel, Arthur E., Fu, Yang-Xin, Chen, Zhijian J., Gao, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500418/
https://www.ncbi.nlm.nih.gov/pubmed/28436963
http://dx.doi.org/10.1038/nnano.2017.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500418/
https://www.ncbi.nlm.nih.gov/pubmed/28436963
http://dx.doi.org/10.1038/nnano.2017.52

Ejemplares similares